Determinants of HAART discontinuation among injection drug users

被引:73
作者
Kerr, T
Marshall, A
Walsh, J
Palepu, A
Tyndall, M
Montaner, J
Hogg, R
Wood, E
机构
[1] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada
[2] St Pauls Hosp, Canadian HIV AIDS Legal Network, Vancouver, BC, Canada
[3] Univ Victoria, Dept Educ Psychol, Victoria, BC V8W 2Y2, Canada
[4] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada
[5] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada
[6] Univ British Columbia, Dept Healthcare & Epidemiol, Vancouver, BC V5Z 1M9, Canada
来源
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 2005年 / 17卷 / 05期
基金
加拿大健康研究院;
关键词
D O I
10.1080/09540120412331319778
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The objective of this study was to identify psychosocial determinants of, and self-reported reasons for, HAART discontinuation among HIV-positive injection drug users (IDUs). We examined correlates between sociodemographic characteristics, drug use and risk behaviors, outcome expectations, adherence self-efficacy, social support and HAART discontinuation among 160 HIV-positive participants in the Vancouver Injection Drug Users' Study (VIDUS). Logistic regression was used to identify the factors independently associated with discontinuation of HAART. Seventy-one (44%) study participants discontinued HAART during the study period. Factors independently associated with discontinuation of HAART included recent incarceration (OR=4.84, p=0.022), negative outcome expectations (OR=1.41, p=0.001), adherence efficacy expectations (OR=0.70, p=0.003) and self-regulatory efficacy (OR=0.86, p=0.050). The most frequently cited reasons provided for discontinuing HAART were being in jail (44%) and medication side effects (41%). The results of this study suggest that psychological constructs derived from self-efficacy theory are highly germane to the understanding of HAART discontinuation behavior and interventions that may change it. Incarceration may result in interruptions in HAART among IDUs, and programmatic changes may be needed to promote optimal retention on HAART among incarcerated HIV-infected IDUs.
引用
收藏
页码:539 / 549
页数:11
相关论文
共 42 条
  • [1] Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008
  • [2] The era of adherence to HIV therapy
    Altice, FL
    Friedland, GH
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 129 (06) : 503 - 505
  • [3] [Anonymous], HIV AIDS PRISONS FIN
  • [4] Social cognitive theory: An agentic perspective
    Bandura, A
    [J]. ANNUAL REVIEW OF PSYCHOLOGY, 2001, 52 : 1 - 26
  • [5] Bandura A., 1986, SOCIAL FDN THOUGHT A
  • [6] Bandura A., 1997, SELF EFFICACY EXERCI
  • [7] Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
    Bangsberg, DR
    Hecht, FM
    Charlebois, ED
    Zolopa, AR
    Holodniy, M
    Sheiner, L
    Bamberger, JD
    Chesney, MA
    Moss, A
    [J]. AIDS, 2000, 14 (04) : 357 - 366
  • [8] Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments
    Chesney, MA
    Ickovics, JR
    Chambers, DB
    Gifford, AL
    Neidig, J
    Zwickl, B
    Wu, AW
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2000, 12 (03): : 255 - 266
  • [9] DEBRUYN T, 1998, HIV AIDS DISCRIMINAT
  • [10] Nonnucleoside reverse transcriptase inhibitor resistance
    Deeks, SG
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 : S25 - S33